Research also suggests that the expression of PD-1 on HBV-specific CD8+ T cells at the earliest time points of infection positively correlate with serum ALT levels, thereby suggesting that early PD-1 expression in patients with chronic hepatitis B may serve as a biomarker for liver damage (53, 54). This evidence concerns the gene PDCD1 and chronic hepatitis B virus infection.